 |
|
Clinical Research Services
Winners leave nothing to chance. Teamwork and experience are key. Selecting the right partner can favorably impact your drug development timelines and decision-making processes.
SGS has over 30 years of experience as a global CRO, providing integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and QC testing. Our state of the art facilities include: Phase I units with a total of 162 beds, bioanalytical labs, and Phase II-IV clinical trial management offices across Europe, North America and Asia.
Taking a drug candidate from preclinical studies through an entire clinical drug development program requires an enormous commitment of resources and bears a number challenges.
SGS serves the pharmaceutical, biotechnology and medical device industries with over 1,300 employees and 2,000 trials performed and can significantly improve client’s drug development timelines and decision-making processes with innovative study designs, optimal facilities, and strong regulatory intelligence.
